Blepharospasm: Clinical Trials

4 trials for Blepharospasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4
Phase 22Completed 2

Follow Blepharospasm: new trials by email Literature Review of Blepharospasm trials Research Report on Blepharospasm

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm
Cannabidiol Oral Solution [Epidiolex] - Blepharospasm, Blepharospasm, Benign Essential
Phase 2 / Phase 3CompletedSilkiss Eye Surgery122020-05-202021-11-02
Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm
Clostridium Botulinum Toxin Type A - Blepharospasm
Phase 2 / Phase 3CompletedDaewoong Pharmaceutical Co. LTD.2342016-10-012019-06-26
IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm
incobotulinumtoxinA (Xeomin), Placebo - Blepharospasm
Phase 3CompletedMerz Pharmaceuticals GmbH1092006-10-012013-03-15
Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm
Korean Botulinum toxin type A (KbtxA) and Botox injection - Blepharospasm
Phase 3CompletedPacific Pharmaceuticals602005-10-012008-05-22

Narrower conditions

Benign essential blepharospasm (1)

Broader conditions

Eye Diseases (4)  ·  Eyelid Diseases (4)

Interventions

Botulinum Toxins, Type A (2)  ·  26S proteasome non-ATPase regulatory subunit 13 (1)  ·  Cannabidiol (1)  ·  incobotulinumtoxinA (1)

Sponsors

Daewoong Pharmaceutical Co. LTD. (1)  ·  Merz Pharmaceuticals GmbH (1)  ·  Pacific Pharmaceuticals (1)  ·  Silkiss Eye Surgery (1)

Countries

South Korea (2)  ·  United States (2)  ·  Canada (1)

Top investigators

Joseph Jankovic, Prof. (1)  ·  Sang Y Lee, MD, phD (1)

Results publications

PMID 19794937, PMID 21520284, PMID 23435927, PMID 37606606